Latest ACUTA CAPITAL PARTNERS, LLC Stock Portfolio
ACUTA CAPITAL PARTNERS, LLC Performance:
2024 Q3: 13.84%YTD: 31.26%2023: 7.39%
Performance for 2024 Q3 is 13.84%, and YTD is 31.26%, and 2023 is 7.39%.
About ACUTA CAPITAL PARTNERS, LLC and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, ACUTA CAPITAL PARTNERS, LLC reported an equity portfolio of $123.5 Millions as of 30 Sep, 2024.
The top stock holdings of ACUTA CAPITAL PARTNERS, LLC are PCVX, OCUL, . The fund has invested 12.5% of it's portfolio in VAXCYTE INC and 8.4% of portfolio in OCULAR THERAPEUTIX INC.
The fund managers got completely rid off SAREPTA THERAPEUTICS INC (SRPT), AGIOS PHARMA (AGIO) and VIRIDIAN THERAPEUTICS INC (VRDN) stocks. They significantly reduced their stock positions in DYNE THERAPEUTICS INC (DYN), CORBUS PHARMACEUTICALS HOLDINGS (CRBP) and PRAXIS PRECISION MEDICINES I (PRAX). ACUTA CAPITAL PARTNERS, LLC opened new stock positions in ASCENDIS PHARMA A/S, COMPASS PATHWAYS PLC (CMPS) and EDGEWISE THERAPEUTICS INC (EWTX). The fund showed a lot of confidence in some stocks as they added substantially to MEREO BIOPHARMA GROUP PLC (MREO), INSMED INC (INSM) and ARGENX SE.
The top stock holdings of ACUTA CAPITAL PARTNERS, LLC are PCVX, OCUL, . The fund has invested 12.5% of it's portfolio in VAXCYTE INC and 8.4% of portfolio in OCULAR THERAPEUTIX INC.
The fund managers got completely rid off SAREPTA THERAPEUTICS INC (SRPT), AGIOS PHARMA (AGIO) and VIRIDIAN THERAPEUTICS INC (VRDN) stocks. They significantly reduced their stock positions in DYNE THERAPEUTICS INC (DYN), CORBUS PHARMACEUTICALS HOLDINGS (CRBP) and PRAXIS PRECISION MEDICINES I (PRAX). ACUTA CAPITAL PARTNERS, LLC opened new stock positions in ASCENDIS PHARMA A/S, COMPASS PATHWAYS PLC (CMPS) and EDGEWISE THERAPEUTICS INC (EWTX). The fund showed a lot of confidence in some stocks as they added substantially to MEREO BIOPHARMA GROUP PLC (MREO), INSMED INC (INSM) and ARGENX SE.
ACUTA CAPITAL PARTNERS, LLC Annual Return Estimates Vs S&P 500
Our best estimate is that ACUTA CAPITAL PARTNERS, LLC made a return of 13.84% in the last quarter. In trailing 12 months, it's portfolio return was 59.86%.
New Buys
| Ticker | $ Bought |
|---|---|
| ascendis pharma a/s | 3,135,510 |
| compass pathways plc | 2,434,950 |
| acelyrin inc | 1,794,520 |
| edgewise therapeutics inc | 1,681,470 |
| gilead sciences inc | 1,634,880 |
| ultragenyx pharmaceutical inc | 1,394,300 |
| unicycive therapeutics inc | 807,315 |
| liquidia corporation | 735,000 |
New stocks bought by ACUTA CAPITAL PARTNERS, LLC
Additions
| Ticker | % Inc. |
|---|---|
| mereo biopharma group plc | 86.22 |
| insmed inc | 49.1 |
| argenx se | 47.5 |
| arcellx inc | 47.16 |
| terns pharmaceuticals inc | 31.88 |
| tourmaline bio inc | 23.17 |
| vaxcyte inc | 22.64 |
| kura oncology inc. common stock | 20.86 |
Additions to existing portfolio by ACUTA CAPITAL PARTNERS, LLC
Reductions
| Ticker | % Reduced |
|---|---|
| dyne therapeutics inc | -78.26 |
| corbus pharmaceuticals holdings | -71.32 |
| praxis precision medicines i | -65.03 |
| ocular therapeutix inc | -57.05 |
| leap therapeutics inc | -38.21 |
| mersana therapeutics inc | -27.84 |
| enliven therapeutics inc | -25.48 |
| rocket pharmaceuticals inc | -24.11 |
ACUTA CAPITAL PARTNERS, LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| viridian therapeutics inc | -2,594,620 |
| oric pharmaceuticals inc | -678,720 |
| agios pharma | -3,393,540 |
| cellectar biosciences inc. | -176,250 |
| pliant therapeutics inc | -496,650 |
| sarepta therapeutics inc | -4,345,000 |
| newamsterdam pharma co nv | -432,225 |
ACUTA CAPITAL PARTNERS, LLC got rid off the above stocks
Sector Distribution
ACUTA CAPITAL PARTNERS, LLC has about 77.7% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 77.7 |
| Others | 22.3 |
Market Cap. Distribution
ACUTA CAPITAL PARTNERS, LLC has about 7.7% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| SMALL-CAP | 29.5 |
| MID-CAP | 29.2 |
| UNALLOCATED | 26.5 |
| LARGE-CAP | 7.7 |
| NANO-CAP | 3.7 |
| MICRO-CAP | 3.3 |
Stocks belong to which Index?
About 62.5% of the stocks held by ACUTA CAPITAL PARTNERS, LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| RUSSELL 2000 | 61.2 |
| Others | 37.4 |
| S&P 500 | 1.3 |
ACUTA CAPITAL PARTNERS, LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of ACUTA CAPITAL PARTNERS, LLC
ACUTA CAPITAL PARTNERS, LLC has 41 stocks in it's portfolio. About 61.6% of the portfolio is in top 10 stocks. RCKT proved to be the most loss making stock for the portfolio. PCVX was the most profitable stock for ACUTA CAPITAL PARTNERS, LLC last quarter.
Last Reported on: 14 Nov, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| AADI | aadi biosciences inc | 3.09 | 1,849,400 | 3,809,770 | unchanged | 0.00 | ||
| ACLX | arcellx inc | 4.20 | 62,100 | 5,185,970 | added | 47.16 | ||
| AGIO | agios pharma | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| BNTC | benitec biopharma inc | 0.22 | 29,800 | 273,862 | new | |||
| CELC | celcuity inc | 0.56 | 46,600 | 694,806 | added | 3.56 | ||
| CLRB | cellectar biosciences inc. | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CMPS | compass pathways plc | 1.97 | 386,500 | 2,434,950 | new | |||
| CRBP | corbus pharmaceuticals holdings | 0.31 | 18,500 | 381,655 | reduced | -71.32 | ||
| CRNX | crinetics pharmaceuticals in | 5.45 | 131,700 | 6,729,870 | reduced | -2.55 | ||
| DYN | dyne therapeutics inc | 1.34 | 46,200 | 1,659,500 | reduced | -78.26 | ||
| ELYM | climb bio inc | 0.22 | 54,000 | 274,860 | new | |||
| EWTX | edgewise therapeutics inc | 1.36 | 63,000 | 1,681,470 | new | |||
| GERN | geron corp | 0.57 | 154,900 | 703,246 | new | |||
| GILD | gilead sciences inc | 1.32 | 19,500 | 1,634,880 | new | |||
| INSM | insmed inc | 6.36 | 107,500 | 7,847,500 | added | 49.1 | ||
| KURA | kura oncology inc. common stock | 3.12 | 197,000 | 3,849,380 | added | 20.86 | ||
| LPTX | leap therapeutics inc | 0.25 | 120,500 | 309,685 | reduced | -38.21 | ||
| LQDA | liquidia corporation | 0.60 | 73,500 | 735,000 | new | |||
| MREO | mereo biopharma group plc | 4.20 | 1,260,700 | 5,181,480 | added | 86.22 | ||
| MRSN | mersana therapeutics inc | 1.84 | 1,200,000 | 2,268,000 | reduced | -27.84 | ||